{"id":5330,"date":"2021-09-07T18:00:46","date_gmt":"2021-09-07T18:00:46","guid":{"rendered":"https:\/\/www.sicklecelldisease.org\/?p=5330"},"modified":"2021-09-07T18:00:46","modified_gmt":"2021-09-07T18:00:46","slug":"marac-issues-updated-covid-19-guidance","status":"publish","type":"post","link":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/","title":{"rendered":"MARAC Issues Updated COVID-19 Guidance"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg\" alt=\"\" width=\"2500\" height=\"521\" class=\"alignnone size-full wp-image-4598\" srcset=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg 2500w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-600x125.jpg 600w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-300x63.jpg 300w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-1024x213.jpg 1024w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-768x160.jpg 768w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-1536x320.jpg 1536w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-2048x427.jpg 2048w, https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3-1568x327.jpg 1568w\" sizes=\"auto, (max-width: 2500px) 100vw, 2500px\" \/><br \/>\nAugust 26, 2021 &#8211; <strong>The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released two statements with updated COVID-19 guidance.<\/strong><br \/>\nMARAC recommendations are making a minor shift to emphasize a more individualized approach:<\/p>\n<ul>\n<li>Continue to recommend vaccination against COVID. For booster dose of vaccine, currently SCD is not eligible but expect changes in CDC guidance.<\/li>\n<li>Continue to recommend general precautions: wearing masks, keeping physical distancing, good ventilation, and washing hands. These are public health measures.<\/li>\n<li>Recommend neutralizing monoclonal antibodies (mAb) &#8211; (Regeneron) as early treatment for mild symptomatic COVID in individuals with SCD [&lt;10d after the test, age 12y+, wt 88 lb+ (40kg+), not hospitalized, not newly on oxygen]. Encourage getting tested if you have COVID symptoms. Possible prophylactic treatment with Regeneron antibodies if exposed to COVID.<\/li>\n<li>No general recommendation for all individuals with SCD to stay home nor all to return to in-person activities. Help patients and families make individualized assessments of risk and trade-offs of returning to work or school in-person. Factors to consider were listed in MARAC July 2020 \u201cchecklist for return to school\u201d (plus vaccination status): the community\u2019s rates of COVID and variants, vaccination status, family socioeconomic situation, ventilation and other protective measures in the building, mental health needs, educational needs.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2021\/09\/MARAC-COVID-update.pdf\">Read the full statement for more information on the above<\/a>.<br \/>\nAdditionally, MARAC recommends that people with sickle cell disease should have access to monoclonal antibody (mAbs) treatment according to established guidelines, to prevent mild COVID from progressing to severe disease. <a href=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2021\/09\/MARAC-statement-mAbs.pdf\">Read the full recommendations for providers, policy makers and patients<\/a>.<br \/>\n&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>August 26, 2021 &#8211; The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released two statements with updated COVID-19 guidance. MARAC recommendations are making a minor shift to emphasize a more individualized approach: Continue to recommend vaccination against COVID. For booster dose of vaccine, currently SCD is not eligible but expect [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,2],"tags":[],"class_list":["post-5330","post","type-post","status-publish","format-standard","hentry","category-marac-statement","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>MARAC Issues Updated COVID-19 Guidance - Sickle Cell Disease Association of America Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MARAC Issues Updated COVID-19 Guidance - Sickle Cell Disease Association of America Inc.\" \/>\n<meta property=\"og:description\" content=\"August 26, 2021 &#8211; The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released two statements with updated COVID-19 guidance. MARAC recommendations are making a minor shift to emphasize a more individualized approach: Continue to recommend vaccination against COVID. For booster dose of vaccine, currently SCD is not eligible but expect [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/\" \/>\n<meta property=\"og:site_name\" content=\"Sickle Cell Disease Association of America Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T18:00:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/\",\"url\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/\",\"name\":\"MARAC Issues Updated COVID-19 Guidance - Sickle Cell Disease Association of America Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg\",\"datePublished\":\"2021-09-07T18:00:46+00:00\",\"dateModified\":\"2021-09-07T18:00:46+00:00\",\"author\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/efc0c6b0f986827becc4515dd736f366\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#primaryimage\",\"url\":\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg\",\"contentUrl\":\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg\",\"width\":2500,\"height\":521},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sicklecelldisease.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MARAC Issues Updated COVID-19 Guidance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#website\",\"url\":\"https:\/\/www.sicklecelldisease.org\/\",\"name\":\"Sickle Cell Disease Association of America Inc.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sicklecelldisease.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/efc0c6b0f986827becc4515dd736f366\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2b80c3a97c5df05f644e48a1b6c6a1f0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2b80c3a97c5df05f644e48a1b6c6a1f0?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/www.sicklecelldisease.org\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MARAC Issues Updated COVID-19 Guidance - Sickle Cell Disease Association of America Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/","og_locale":"en_US","og_type":"article","og_title":"MARAC Issues Updated COVID-19 Guidance - Sickle Cell Disease Association of America Inc.","og_description":"August 26, 2021 &#8211; The Sickle Cell Disease Association of America Medical and Research Advisory Committee has released two statements with updated COVID-19 guidance. MARAC recommendations are making a minor shift to emphasize a more individualized approach: Continue to recommend vaccination against COVID. For booster dose of vaccine, currently SCD is not eligible but expect [&hellip;]","og_url":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/","og_site_name":"Sickle Cell Disease Association of America Inc.","article_published_time":"2021-09-07T18:00:46+00:00","og_image":[{"url":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg","type":"","width":"","height":""}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/","url":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/","name":"MARAC Issues Updated COVID-19 Guidance - Sickle Cell Disease Association of America Inc.","isPartOf":{"@id":"https:\/\/www.sicklecelldisease.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#primaryimage"},"image":{"@id":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg","datePublished":"2021-09-07T18:00:46+00:00","dateModified":"2021-09-07T18:00:46+00:00","author":{"@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/efc0c6b0f986827becc4515dd736f366"},"breadcrumb":{"@id":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#primaryimage","url":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg","contentUrl":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2020\/12\/H-1404-MARAC-Alert-new-header-for-Constant-Contact_300ppi3.jpg","width":2500,"height":521},{"@type":"BreadcrumbList","@id":"https:\/\/www.sicklecelldisease.org\/2021\/09\/07\/marac-issues-updated-covid-19-guidance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sicklecelldisease.org\/"},{"@type":"ListItem","position":2,"name":"MARAC Issues Updated COVID-19 Guidance"}]},{"@type":"WebSite","@id":"https:\/\/www.sicklecelldisease.org\/#website","url":"https:\/\/www.sicklecelldisease.org\/","name":"Sickle Cell Disease Association of America Inc.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sicklecelldisease.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/efc0c6b0f986827becc4515dd736f366","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2b80c3a97c5df05f644e48a1b6c6a1f0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2b80c3a97c5df05f644e48a1b6c6a1f0?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/www.sicklecelldisease.org\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/5330","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/comments?post=5330"}],"version-history":[{"count":0,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/5330\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/media?parent=5330"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/categories?post=5330"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/tags?post=5330"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}